Dr. John Bell received his PhD from McMaster University in 1982. In the following three years he trained as a post-doctoral fellow at the University of Ottawa and then at the Medical Research Council in London England. Dr. Bell began his independent research career at McGill University in 1986 and moved to the University of Ottawa, Department of Medicine in 1989. He is a member of the Center for Cancer Therapeutics at the Ottawa Hospital Regional Cancer Center, a Senior Scientist with the Ottawa Health Research Institute and Professor of Medicine at the University of Ottawa. He heads the Canadian Oncolytic Virus Consortium, a Terry Fox funded group from across Canada that is developing virus based cancer therapeutics. He is a member of the National Cancer Institute of Canada (NCIC) Clinical Trials Group Executive Committee and currently is Chair of the NCIC Cell Growth and Metastasis Panel.